Register for streaming realtime charts, analysis tools, and prices.
Period:
Draw Mode:
| Volume | 6,952 |
|
|||||
| News | - | ||||||
| Day High | 3.56 | Low High |
|||||
| Day Low | 3.42 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Aspira Womans Health Inc | AWH | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| -0.04 | -1.13% | 3.49 | 16:00:06 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 3.48 | 3.42 | 3.56 | 3.49 | 3.53 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 80 | 6,952 | $ 3.48 | $ 24,164 | - | 2.3087 - 6.75 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 16:00:00 | 142 | $ 3.49 | USD |
Aspira Womans Health Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 41.35M | 10.34M | - | 8.18M | -27.17M | -2.63 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Aspira Womans Health News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical AWH Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 3.18 | 3.6299 | 3.17 | 3.46 | 13,276 | 0.31 | 9.75% |
| 1 Month | 3.60 | 3.75 | 2.51 | 3.09 | 27,893 | -0.11 | -3.06% |
| 3 Months | 4.31 | 5.65 | 2.51 | 3.96 | 26,532 | -0.82 | -19.03% |
| 6 Months | 5.48 | 6.0142 | 2.49 | 3.92 | 37,942 | -1.99 | -36.31% |
| 1 Year | 5.55 | 6.75 | 2.3087 | 4.17 | 67,903 | -2.06 | -37.12% |
| 3 Years | 90.0525 | 95.85 | 2.3087 | 26.36 | 433,030 | -86.56 | -96.12% |
| 5 Years | 62.10 | 158.10 | 2.3087 | 43.99 | 507,813 | -58.61 | -94.38% |
Aspira Womans Health Description
| Aspira Womens Health Inc is transforming women's health with the discovery, development, and commercialization of testing options and bio-analytical solutions that help physicians assess risk, optimize patient management and improve gynecologic health outcomes for women. OVA1 plus combines its FDA-cleared products OVA1 and OVERA to detect the risk of ovarian malignancy in women with adnexal masses. Aspira GenetiX testing offers both targeted and more comprehensive genetic testing options with a gynecologic focus. Its focus is on delivering products that allow healthcare providers to stratify risk, facilitate early detection, and optimize treatment. |
